Author | Anthony R. Mato, MD, MSCE | OncLive

Author | Anthony R. Mato, MD, MSCE

Articles

Dr. Mato on the Efficacy of Fixed-Duration Venetoclax-Based Combo in CLL

April 08, 2020

Video

Anthony R. Mato, MD, MSCE, discusses the phase III CLL14 trial, which evaluated the efficacy of fixed-duration treatment with venetoclax plus obinutuzumab in patients with chronic lymphocytic leukemia.

Dr. Mato on the CLL14 Trial Results in CLL

December 19, 2019

Video

Anthony R. Mato, MD, MSCE, discusses the phase III CLL14 trial in patients with previously untreated chronic lymphocytic leukemia.

Dr. Mato on Ibrutinib Versus Acalabrutinib in CLL

November 23, 2019

Video

Anthony R. Mato, MD, MSCE, discusses differences between the use of ibrutinib (Imbruvica) and acalabrutinib (Calquence) in chronic lymphocytic leukemia (CLL).

Dr. Mato on Ibrutinib-Based Combinations in CLL

November 21, 2019

Video

Anthony R. Mato, MD, MSCE, discusses ibrutinib-based combinations in chronic lymphocytic leukemia.

x